Pfizer’s inhibitor drug given Breakthrough Therapy designation by FDA
Pfizer recently made an announcement confirming that its experimental oral inhibitor, Janus kinase 3 (JAK3)…
NHS taps personalized medicine, uses iconic drug for cancer treatment
The National Health Service (NHS), the national healthcare system of England, has reportedly made plans…
Microsoft introduces hi-tech glasses that monitor blood pressure
Software behemoth Microsoft is reportedly developing technologically advanced spectacles that incessantly monitor blood pressure all…
CHAOS approach taps CRISPR to alter multiple genes in bacterial cells
Researchers at the University of Colorado Boulder have reportedly developed an unconventional genetic disruption strategy…
HCA Healthcare to buy Mission Health, deal awaits regulatory approval
Renowned for-profit healthcare facility provider, HCA Healthcare, based out of Nashville, has seemingly made it…
Pfizer brings the development of DMD candidate Domagrozuma to a halt
Renowned New York-based pharma magnate Pfizer Inc., has reportedly axed two trials of its Domagrozuma…
Alibaba unveils online service for doctor consultation, meds delivery
Alibaba, the Chinese multinational giant, has recently launched an online medical consultation and 24-hour medicine…
AstraZeneca phase III lupus-drug trial fails to meet primary goal
AstraZeneca along with its global biologics research and development business, MedImmune, has reportedly announced that…
Voluntis & AstraZeneca advance collaboration in the field of oncology
Voluntis, a medical intelligence firm that develops advanced digital therapeutics to enhance medications and medical…